Capturing cognition

We’ve discussed already how the use of biomarkers, for example using neuroimaging and analysis of cerebrospinal fluid, can help us pick up on disease processes before obvious cognitive symptoms may become apparent.

Here Craig describes how, if we also want to be able to detect problems with memory and thinking much earlier in the course of disease, we have to think about which parts of the brain are affected earliest and how can we specifically test those areas?